8-K
Current Report
Compass Therapeutics, Inc. Filed Acc 0001171843-26-004224
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading f8k_062226.htm…